University Hospital Regensburg
Bruno L. Cadilha currently serves as a resident doctor for Hematology and Oncology at University Hospital Regensburg since January 2024. Prior to this position, Bruno held the role of Associate Director for Cellular Therapies at Vector BioPharma from May 2022 to November 2023, where leadership of a team of three scientists focused on preclinical development in cell and gene therapy was a key responsibility. Bruno's extensive experience includes serving as Lead of Animal Experimentation for Cellular Therapies at Ludwig-Maximilians-Universität München, alongside various teaching and project management roles within the institution. Bruno's academic background features a PhD in Immunology and Oncology from Ludwig-Maximilians-Universität München, complemented by a Master's degree in Pneumology and Hemodynamics and a Doctor of Medicine from the University of Lisbon. Additional international research experience includes positions at Massachusetts General Hospital and Herlev Hospital.
This person is not in any teams
University Hospital Regensburg
Regensburg University Hospital is a centre of research, teaching and patient care. We are a first-class employer for a staff of over 4900 colleagues, who provide the highest level of medical care in the region. In all areas of medicine, our top-ranking staff are equipped with the latest technology. Our mission is to provide our patients with the best possible medical and nursing care, while ensuring our team members receive the esteem they deserve.